" class="no-js "lang="en-US"> Diseases Archives - Page 108 of 139 - Medtech Alert
Tuesday, May 05, 2026

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

NHS Offers Home Blood Pressure Checks to Save Thousands of Lives

Hundreds of thousands of people will be able to test their blood pressure at home, […]

LumiraDx Announces the Intended Use for its FDA EUA Authorized High Sensitivity COVID-19 Antigen Test has been Expanded to Include Testing of Asymptomatic Individuals

Today, LumiraDx (Nasdaq: LMDX) a next-generation point of care (POC) diagnostics company announced that the intended use for its Food […]

Walk-in Sites Open Up For People To Get Covid-19 Booster Jab

Hundreds of walk-in sites across the country are now offering booster vaccines as the NHS […]

BHF Teams Up With The Francis Crick Institute to Bolster Cardiovascular Research

BHF have teamed up with the Francis Crick Institute to improve understanding of cardiovascular health […]

Novavax Files for Authorization of its COVID-19 Vaccine in the United Kingdom

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious […]

Freenome Shows Continued Leadership in Colorectal Cancer Research

Freenome, a privately held biotech company, presented new research at the American College of Gastroenterology […]

Heidelberg Ion Beam Therapy Center Treats First Patient Using Helium Ion Therapy with RayStation

Heidelberg Ion Beam Therapy Center (HIT) has treated its first patient using helium ion therapy […]

Hummingbird Bioscience to Collaborate with Merck on Clinical Trial of Anti-VISTA Antibody HMBD-002 in Combination with KEYTRUDA® (Pembrolizumab) for Treatment of Cancer

Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets […]

Titan Pharmaceuticals Receives Funding to Develop Combination HIV Therapeutic and Contraceptive Implant for Women in Developing Countries

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that it has received funding […]

Accuray CyberKnife® Robotic Radiotherapy Platform Could Significantly Improve Survival in Early-Stage Breast Cancer Patients

Accuray Incorporated (NASDAQ: ARAY) announced today that a study published in Frontiers in Oncology found early-stage breast cancer patients […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more